Search - tctmd.com

Displaying 161 - 180 of 465

Sort: Relevancy | Date

Presentation TCT 2019

Update on Target BP Trials Program (Chemical Renal Denervation): Lessons Learned, Ongoing Efforts

Presenter: Felix Mahfoud

September 28, 2019

Presentation TCT 2019

Update on RADIANCE Trials Program (Ultra-Sound Renal Denervation): Lessons Learned, Ongoing Efforts

Presenter: Ajay Kirtane

September 28, 2019

Presentation TCT 2019

Update on SPRYRAL Trials Program (Radiofrequency Renal Denervation): Lessons Learned, Ongoing Efforts

Presenter: Michael Boehm

September 28, 2019

Presentation TCT 2019

Patient Preferences in Hypertension Treatment

Presenter: David Kandzari

September 28, 2019

Presentation TCT 2019

Non-Adherence in Uncontrolled Hypertension: How to Assess and Manage?

Presenter: Roland Schmieder

September 28, 2019

Presentation TCT 2019

Race-Based Differences in Hypertension Management: What’s Relevant?

Presenter: Clyde Yancy

September 28, 2019

Presentation TCT 2019

Sex-Based Differences in Hypertension Management: Do They Exist?

Presenter: Ileana Pina

September 28, 2019

Presentation TCT 2019

The Essentials of Blood Pressure Measurement: Office, Home, and Ambulatory — And Why It Matters

Presenter: Michael Weber

September 28, 2019

Presentation TCT 2019

In Case You Missed It: What’s Happened (So Very) Recently in Renal Denervation

Presenter: Andrew Sharp

September 28, 2019

Presentation TCT 2019

Clinical Context of SOLO and Future Results and Implications for Who to Treat

Presenter: Naomi Fisher

September 27, 2019

Presentation TCT 2019

RADIANCE-HTN SOLO: In-Depth Analysis at 6 Months After Medication Titration and Review of RADIANCE-HTN Global Clinical Trial Program

Presenter: Ajay Kirtane

September 27, 2019

Presentation TCT 2019

RDN Procedure With the ReCor Paradise Technology: Anatomy, Treatment Location, Procedure Standardization and Simplicity

Presenter: Chandan Devireddy

September 27, 2019

Presentation TCT 2019

Introduction to Session

Presenter: Ajay Kirtane

September 27, 2019

Presentation TCT 2019

Alcohol-Mediated Renal Denervation: 1-Year and Final Results From the Peregrine Postmarket Study

Presenter: Felix Mahfoud

September 27, 2019

Presentation TCT 2019

Endovascular Renal Sympathetic Denervation to Improve Heart Failure With Reduced Ejection Fraction: The IMPROVE HF-I Study

Presenter: Joost Daemen

September 27, 2019

Presentation TCT 2019

The Target BP Program: Ongoing and Future Studies

Presenter: David Kandzari

September 27, 2019

Presentation TCT 2019

Clinical Evaluation: Peregrine Results to Date

Presenter: Felix Mahfoud

September 27, 2019

Presentation TCT 2019

Procedure Overview: Alcohol-mediated RDN Using the Peregrine System

Presenter: Horst Sievert

September 27, 2019

Presentation TCT 2019

Alcohol-Mediated Renal Denervation: How is it Different?

Presenter: Melvin Lobo

September 27, 2019

Presentation TCT 2019

TCT 607: Optimizing Safety and Efficacy of Lesion Formation for Percutaneous Renal Denervation: Human and Porcine Histological Analysis

Presenter: Andrew Sharp

September 25, 2019

Advertisement

Update on Target BP Trials Program (Chemical Renal Denervation): Lessons Learned, Ongoing Efforts

Update on RADIANCE Trials Program (Ultra-Sound Renal Denervation): Lessons Learned, Ongoing Efforts

Update on SPRYRAL Trials Program (Radiofrequency Renal Denervation): Lessons Learned, Ongoing Efforts

Patient Preferences in Hypertension Treatment

Non-Adherence in Uncontrolled Hypertension: How to Assess and Manage?

Race-Based Differences in Hypertension Management: What’s Relevant?

Sex-Based Differences in Hypertension Management: Do They Exist?

The Essentials of Blood Pressure Measurement: Office, Home, and Ambulatory — And Why It Matters

In Case You Missed It: What’s Happened (So Very) Recently in Renal Denervation

Clinical Context of SOLO and Future Results and Implications for Who to Treat

RADIANCE-HTN SOLO: In-Depth Analysis at 6 Months After Medication Titration and Review of RADIANCE-HTN Global Clinical Trial Program

RDN Procedure With the ReCor Paradise Technology: Anatomy, Treatment Location, Procedure Standardization and Simplicity

Introduction to Session

Alcohol-Mediated Renal Denervation: 1-Year and Final Results From the Peregrine Postmarket Study

Endovascular Renal Sympathetic Denervation to Improve Heart Failure With Reduced Ejection Fraction: The IMPROVE HF-I Study

The Target BP Program: Ongoing and Future Studies

Clinical Evaluation: Peregrine Results to Date

Procedure Overview: Alcohol-mediated RDN Using the Peregrine System

Alcohol-Mediated Renal Denervation: How is it Different?

TCT 607: Optimizing Safety and Efficacy of Lesion Formation for Percutaneous Renal Denervation: Human and Porcine Histological Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content